Functional Constipation Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies – Gelesis, Allergan, Renexxion, Takeda, and Synergy Pharmaceuticals

Functional Constipation Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - Gelesis, Allergan, Renexxion, Takeda, and Synergy Pharmaceuticals
Delveinsight Business Research LLP

DelveInsight’s “Functional Constipation Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Functional Constipation Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Functional Constipation market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Functional Constipation Market

Functional Constipation: An Overview

Functional Constipation (FC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. FC is also referred to as chronic idiopathic constipation (CIC), as FC is classified as one of the functional gastrointestinal disorders (FGDs). It is estimated that approximately 14% of the population experiences chronic constipation. Possible FC causes could be a reduction in fluid and fiber intake in the diet, changes in water balance, and changes in contractility of the colon.

Functional Constipation Market Key Facts

  • As per ADA Health, eight million people in the US seek medical care for constipation every year, and one million are hospitalized. It is likely that many people who have FC do not report the condition to their doctors because they are embarrassed or do not see it as a major problem requiring medical care.

  • According to a study by Black et al. (2018), titled “Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management”, the prevalence of FC increases with age, with higher rates reported in older people.

  • According to the 2019 article published in the American Journal of Managed Care (AJMC) titled “Update on the Management of Chronic Idiopathic Constipation” by the doctor, Brian E. Lacy stated that both patients and healthcare providers had documented unmet needs with currently available therapeutic options for FC. The prompting research for new agents with novel mechanisms of action are much needed that are both efficacious and safe.

Functional Constipation Market

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Functional Constipation market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Functional Constipation market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Functional Constipation Epidemiology

The epidemiology section covers insights about the historical and current Functional Constipation patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Functional Constipation Epidemiology Subtype Segmentation

  • Prevalent Population of Functional Constipation

  • Age-specific Prevalent Population of Functional Constipation

  • Gender-specific Prevalent Population of Functional Constipation

  • Diagnosed and Treatable Cases of Functional Constipation

Functional Constipation Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Functional Constipation market or expected to get launched in the market during the study period. The analysis covers Functional Constipation market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Functional Constipation Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Functional Constipation Therapeutics Analysis

The dynamics of the Functional Constipation treatment paradigm has a major obstacle where the exact cause is still not known due to which it is not possible to determine definitive treatment for the indication. Although there are several approved drugs for Functional Constipation, still a need for developing targeted therapies.

The treatment options for FC include Dietary Fiber, Laxatives, and Medications. At present some of the key players are diligently involved in the therapeutics development which is expected to change the treatment scenario.

Get the PDF Sample of the Report:-

Some of the key companies in the Functional Constipation Market include:

  • Gelesis

  • Allergan

  • Renexxion

  • Takeda Pharmaceuticals

  • Synergy Pharmaceuticals

And others.

Functional Constipation Therapies covered in the report include:

  • GS500

  • Naronapride

And many more.

Get More Detailed Insights into the Emerging Therapies & Key Companies:-

Table of Content

1. Key Insights

2. Executive Summary 

3. Functional Constipation Competitive Intelligence Analysis

4. Functional Constipation Market Overview at a Glance

5. Functional Constipation Disease Background and Overview

6. Functional Constipation Patient Journey

7. Functional Constipation Epidemiology and Patient Population

8. Functional Constipation Treatment Algorithm, Current Treatment, and Medical Practices

9. Functional Constipation Unmet Needs

10. Key Endpoints of Functional Constipation Treatment

11. Functional Constipation Marketed Products

12. Functional Constipation Emerging Therapies

13. Functional Constipation Seven Major Market Analysis

14. Attribute Analysis

15. Functional Constipation Market Outlook (7 major markets)

16. Functional Constipation Access and Reimbursement Overview

17. KOL Views on the Functional Constipation Market.

18. Functional Constipation Market Drivers

19. Functional Constipation Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:-

Trending Healthcare Reports By DelveInsight

Follicular Lymphoma Market

DelveInsight’s “Follicular Lymphoma Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). As per DelveInsight, Follicular Lymphoma Market is expected to grow immensely in the coming years owing to the active participation of the key companies such as Epizyme, Eisai, Bayer Healthcare Pharmaceuticals, Verastem Oncology, Gilead Sciences, TG Therapeutics, Bristol-Myers-Squibb, Roche, Incyte Corporation, Bristol Myers Squibb, ADC Therapeutics, MorphoSys, Nordic Nanovector, AbbVie, Regeneron Pharmaceuticals, Janssen Research & Development, Novartis, MEI Pharma, BeiGene, and others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States